1. Bortezomib inhibited the progression of diffuse large B-cell lymphoma via targeting miR-198
   Ruihuan Wang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
2. GRP75‐mediated upregulation of HMGA1 stimulates stage I lung adenocarcinoma progression by activating JNK/c‐JUN signaling
   Guo‐Bing Qiao et al, 2021, Thoracic Cancer CrossRef
3. SIRT1: a potential tumour biomarker and therapeutic target
   Bin Zhao et al, 2019, Journal of Drug Targeting CrossRef
4. Discovering the Protective Effects of Resveratrol on Aflatoxin B1-Induced Toxicity: A Whole Transcriptomic Study in a Bovine Hepatocyte Cell Line
   Marianna Pauletto et al, 2021, Antioxidants CrossRef
5. Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining
   Wen-Jie Chen et al, 2017, Oncotarget CrossRef
6. SIRT1 alleviates isoniazid-induced hepatocyte injury by reducing histone acetylation in the IL-6 promoter region
   Yiyang Zhang et al, 2019, International Immunopharmacology CrossRef
7. Differential expression of the sirtuin family in renal cell carcinoma: Aspects of carcinogenesis and prognostic significance
   Seong Uk Jeh et al, 2017, Urologic Oncology: Seminars and Original Investigations CrossRef
8. HMGA1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report
   Lias Saed et al, 2022, Molecular Genetics and Genomics CrossRef
9. HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer
   Cuiling Qi et al, 2018, The Anatomical Record CrossRef
10. Deregulation of a Cis-Acting lncRNA in Non-small Cell Lung Cancer May Control HMGA1 Expression
    Greg L. Stewart et al, 2021, Frontiers in Genetics CrossRef
11. SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the CXCR4/CXCL12 axis
    Hongsheng Fang et al, 2022, Cellular Immunology CrossRef
12. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR
    Yue-ya Liang et al, 2018, World Journal of Surgical Oncology CrossRef
13. Sirt1 protects from K‐Ras‐driven lung carcinogenesis
    Luis Filipe Costa‐Machado et al, 2018, EMBO reports CrossRef
14. Prognostic and clinicopathological significance of SIRT1 expression in NSCLC: a meta-analysis
    Yifei Chen et al, 2017, Oncotarget CrossRef
15. Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma
    Xue Wen et al, 2020, Digestive Diseases and Sciences CrossRef
16. HMGA1 in cancer: Cancer classification by location
    Yuhong Wang et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
17. Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy
    Renata Veselska et al, 2019, Frontiers in Oncology CrossRef
18. Survival and Clinicopathological Significance of SIRT1 Expression in Cancers: A Meta-Analysis
    Min Sun et al, 2019, Frontiers in Endocrinology CrossRef
19. Prognostic Significance of HMGA1 Expression in Lung Cancer Based on Bioinformatics Analysis
    Lias Saed et al, 2022, International Journal of Molecular Sciences CrossRef